SCHEMBL7608741

SCHEMBL7608741

CCCOCn1c(=O)c2c(ncn2Cc2ccccc2)n(-c2ccccc2)c1=O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 1/20 0.53
▸ HIF1A Q16665 1/20 0.53
▸ SMN1; SMN2 Q16637 3/20 0.52
▸ ADORA2B P29275 1/20 0.52
▸ RXFP1 Q9HBX9 1/20 0.52
▸ ALDH1A1 P00352 1/20 0.49
▸ PDE1A P54750 1/20 0.48
▸ PDE1B Q01064 1/20 0.48
▸ PDE1C Q14123 1/20 0.48
▸ KMT2A Q03164 6/20 0.47
▸ MEN1 O00255 4/20 0.46
▸ PDE4A P27815 2/20 0.46
▸ HPGD P15428 2/20 0.45
▸ KDM4E B2RXH2 1/20 0.45
▸ LMNA P02545 1/20 0.45
▸ TSHR P16473 1/20 0.45
▸ MAPK1 P28482 1/20 0.45
▸ PDE4B Q07343 1/20 0.44
▸ PDE4C Q08493 1/20 0.44
▸ PDE4D Q08499 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7605727 0.88 KMT2A (0.55) POLBHIF1ASMN1; SMN2ADORA2BRXFP1
SCHEMBL13986116 0.87 POLB (0.59) POLBHIF1ASMN1; SMN2ADORA2BRXFP1
SCHEMBL6662449 0.85 POLB (0.59) POLBHIF1ASMN1; SMN2ADORA2BRXFP1
SCHEMBL7606356 0.85 PDE1A (0.67) POLBHIF1ASMN1; SMN2ADORA2BRXFP1
SCHEMBL6665236 0.84 KMT2A (0.51) POLBHIF1ASMN1; SMN2ADORA2BRXFP1
SCHEMBL7607915 0.83 ALDH1A1 (0.50) POLBHIF1ASMN1; SMN2ADORA2BRXFP1
SCHEMBL6660921 0.82 KMT2A (0.54) POLBHIF1ASMN1; SMN2ADORA2BRXFP1
SCHEMBL20989098 0.81 POLB (0.56) POLBHIF1ASMN1; SMN2ADORA2BRXFP1
SCHEMBL27482324 0.81 POLB (0.56) POLBHIF1ASMN1; SMN2ADORA2BRXFP1
SCHEMBL7606543 0.81 POLB (0.57) POLBHIF1ASMN1; SMN2ADORA2BRXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0812844-B1 Use of theophyllin derivatives for the treatment and prophylaxis fo shock conditions, novel xanthine compounds and processes for the production thereof HOECHST AG (DE) 2002-10-23 — — EP disclosed
US-6214992-B1 THEOPHYLLINE DERIVATIVES HAVING AT LEAST ONE ETHER FUNCTION IN METHYL RADICAL; XANTHINE COMPOUNDS WITH THIS SUBSTITUTION PATTERN USED AS ANTISHOCK TREATMENT HOECHST AKTIENGESELLSCHAFT (DE) 2001-04-10 — — US disclosed
EP-0812844-A2 Use of theophyllin derivatives for the treatment and prophylaxis fo shock conditions, novel xanthine compounds and processes for the production thereof HOECHST AKTIENGESELLSCHAFT (DE) 1997-12-17 — — EP disclosed
Send feedback